Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11941245 | 0.88 | MAPT (0.35) | MEN1KMT2AMAPTCSF1RPDGFRB | |
| SCHEMBL11941238 | 0.86 | MEN1 (0.41) | MEN1KMT2AMAPTCSF1RPDGFRB | |
| SCHEMBL11941221 | 0.86 | GPR3 (0.39) | MEN1KMT2AMAPTRAB9AALOX5 | |
| SCHEMBL11941219 | 0.82 | TDO2 (0.42) | MAPTNPC1RAB9AALOX5TDO2 | |
| SCHEMBL11941237 | 0.82 | MAPT (0.44) | MEN1KMT2AMAPTCSF1RPDGFRB | |
| SCHEMBL22409671 | 0.82 | ALOX5 (0.34) | MEN1KMT2AMAPTNPC1USP2 | |
| SCHEMBL18090106 | 0.80 | NPC1 (0.33) | MAPTNPC1PRKDC | |
| SCHEMBL18090111 | 0.80 | PRKDC (0.30) | ESR2PRKDCESR1 | |
| SCHEMBL18090102 | 0.79 | ALOX5 (0.30) | ALOX5PRKDC | |
| SCHEMBL18090097 | 0.79 | NPC1 (0.33) | MAPTNPC1ALOX5PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415031-B2 | Electron transporting compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-09 | — | — | US | disclosed |
| US-8415031-B2 | Electron transporting compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-09 | — | — | US | disclosed |
| US-20120187381-A1 | Electron Transporting Compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120187381-A1 | Electron Transporting Compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120187381-A1 | Electron Transporting Compounds | SLC19A2, ABCB7, SLCO2B1 | MEN1 3293/4885KMT2A 2879/4885MAPT 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.